(Q54763952)

3 June 2018

title

Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. (English)

1 reference

3 June 2018

0 references

0 references

0 references

1 reference

Jorge Elias Kalil Filho

7

object named as

Jorge Kalil

1 reference

3 June 2018

author name string

Paulo L Bittencourt

1

1 reference

3 June 2018

Selma A Palácios

2

1 reference

3 June 2018

Eduardo L R Cançado

3

1 reference

3 June 2018

Gilda Porta

4

1 reference

3 June 2018

Flair J Carrilho

5

1 reference

3 June 2018

Antonio A Laudanna

6

1 reference

3 June 2018

Anna C Goldberg

8

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 June 2018

The American Journal of Gastroenterology

published in

1 reference

3 June 2018

volume

98

1 reference

3 June 2018

issue

7

1 reference

3 June 2018

page(s)

1616-1620

1 reference

3 June 2018

Diagnosis and treatment of autoimmune hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

The expanding world of co-stimulation: the two-signal model revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor α polymorphisms at position −308

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.07525.X

10.1111/J.1572-0241.2003.07525.X

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018